PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2022.2512023552671-683Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment ResponseJung Yong Hong, Hee Jin Cho, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Sang Kyum Kim, Yurimi Lee, Yoon-La Choi, Minsuk Kwon, Hyo Song Kim, Jeeyun Leehttp://e-crt.org/upload/pdf/crt-2022-251.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2022.251, http://e-crt.org/upload/pdf/crt-2022-251.pdf
OncoTargets and Therapy10.2147/ott.s322002013217Targeted treatment for advanced soft tissue sarcoma: profile of pazopanibSeth Pollack, Jones, Rajendrahttps://www.dovepress.com/getfile.php?fileID=15506
The Lancet10.1016/s0140-6736(12)60739-9201237998291854-1856Pazopanib and the treatment palette for soft-tissue sarcomaVivien HC Bramwellhttps://api.elsevier.com/content/article/PII:S0140673612607399?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673612607399?httpAccept=text/plain
Forum of Clinical Oncology10.1515/fco-2015-001220156313-21The role of Pazopanib in Soft Tissue Sarcoma: A comprehensive review of the literatureGeorge Fotopoulos, George Pentheroudakishttp://content.sciendo.com/view/journals/fco/6/3/article-p13.xml, https://www.sciendo.com/article/10.1515/fco-2015-0012
Clinical Pharmacology: Advances and Applications10.2147/cpaa.s33195201265Pazopanib for the treatment of soft-tissue sarcomaIsabelle Ray-Coquard, Cassier, Derbel, Dufresne, Meeus, Thiesse, Ranchere-Vince, Blay, Heudelhttps://www.dovepress.com/getfile.php?fileID=14333
Community Oncology10.1016/j.cmonc.2012.09.0052012911334-335Pazopanib in advanced soft tissue sarcomaJame Abrahamhttps://api.elsevier.com/content/article/PII:S1548531512005700?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1548531512005700?httpAccept=text/plain
Journal of Clinical Medicine10.3390/jcm801006020198160Relative Dose Intensity of Induction-Phase Pazopanib Treatment of Soft Tissue Sarcoma: Its Relationship with Prognoses of Pazopanib RespondersKenji Nakano, Yuki Funauchi, Keiko Hayakawa, Taisuke Tanizawa, Keisuke Ae, Seiichi Matsumoto, Shunji Takahashihttps://www.mdpi.com/2077-0383/8/1/60/pdf
The Lancet10.1016/s0140-6736(12)61440-820123809844801Pazopanib for metastatic soft-tissue sarcomaMakoto Endo, Torsten O Nielsenhttps://api.elsevier.com/content/article/PII:S0140673612614408?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673612614408?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdt460.36201324ix73Pazopanib for Advanced Soft Tissue SarcomaH. Takamori, T. Karasuno, N. Nishiurahttps://api.elsevier.com/content/article/PII:S092375341933368X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092375341933368X?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/24/suppl_9/ix73/6678506/mdt460.36.pdf
Journal of Thoracic Oncology10.1097/jto.0b013e3182a4700d201491e4-e6Complete Pathologic Response in Soft Tissue Sarcoma Lung Metastases with PazopanibZeynep Eroglu, Jae Kim, Sharon Wilczynski, Warren A. Chowhttps://api.elsevier.com/content/article/PII:S1556086415301763?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086415301763?httpAccept=text/plain